Physiological Reconditioning Program Administered Remotely in Patients Undergoing Transcatheter Aortic Valve Replacement: A Pilot Study (PREPARE-TAVR)
Primary Purpose
Frailty, Transcatheter Aortic Valve Replacement, Rehabilitation
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Remotely administered physiological reconditioning program
Sponsored by
About this trial
This is an interventional treatment trial for Frailty
Eligibility Criteria
Inclusion Criteria:
- Short Physical Performance Battery Protocol (SPPB) score < 9
Exclusion Criteria:
- Severe liver disease defined by Childs Pugh class >B or MELD score >15.
- Severe kidney disease defined by eGFR <30 mL/min.
- Hospital admission during the 4 weeks prior to randomization.
- Montreal objective cognitive assessment (MOCA) score <18.
- Mechanical fall in the past month.
- Unstable angina during the previous month.
- Myocardial infarction during the previous month.
- Unsuccessful completion of the one-week run-in phase.
- Syncopal episode during exercise during run-in phase
Sites / Locations
- Southlake HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
SOC
RAPR
Arm Description
Standard of Care
Remotely administered physiological reconditioning program
Outcomes
Primary Outcome Measures
Quality of Life (QOL)
Quality of life as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). KCCQE is a 23-item self-administered questionnaire developed to independently measure the patient's perception of their health status, which includes heart failure symptoms, impact on physical and social function, and how their heart failure impacts their quality of life (QOL) within a 2-week recall period. KCCQ responses are provided along a rating scale continuum with equal spacing from worst to best.
Secondary Outcome Measures
LOS
Length of stay post TAVR
MACE
Composite of mortality and repeat hospitalization
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03801460
Brief Title
Physiological Reconditioning Program Administered Remotely in Patients Undergoing Transcatheter Aortic Valve Replacement: A Pilot Study
Acronym
PREPARE-TAVR
Official Title
Physiological Reconditioning Program Administered Remotely in Patients Undergoing Transcatheter Aortic Valve Replacement Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
March 31, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Unity Health Toronto
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The PREPARE TAVR pilot study will examine the effects of remotely administered physiological reconditioning program (RAPR) on quality of life (QOL) and clinical outcomes at one year post TAVR in frail older adults.
Detailed Description
The main objective of this study is to evaluate the effects of a home based exercise and dietary intervention program on the quality of life (QOL) and clinical outcomes in frail adults undergoing Transcatheter aortic valve replacement (TAVR) procedures. Patients will be randomly (1:1) assigned to the standard of care (SOC group) where patients will receive all medical care as decided by their treating physicians or assigned to a home based program known as remotely administered physiological reconditioning (RPR) program which will include receiving personalized instructions for a progressive exercise program and dietary changes. Patients will be contacted for regular phone and in-person follow up for monitoring their progress. The primary endpoint will be quality of life as assessed by KCCQE questionnaires at one-year post TAVR. The secondary endpoints include length of stay post TAVR, all-cause mortality, repeat hospitalization and a composite of all-cause mortality and repeat hospitalization at one year.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frailty, Transcatheter Aortic Valve Replacement, Rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, multicenter, randomized trial with objective end points assessment
Masking
Outcomes Assessor
Masking Description
The outcomes assessed in a blinded manner
Allocation
Randomized
Enrollment
160 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
SOC
Arm Type
No Intervention
Arm Description
Standard of Care
Arm Title
RAPR
Arm Type
Experimental
Arm Description
Remotely administered physiological reconditioning program
Intervention Type
Other
Intervention Name(s)
Remotely administered physiological reconditioning program
Intervention Description
Patients assigned to intervention arm will be provided a personalized, tailored and graduated exercise program to improve physical strength and conditioning.
Primary Outcome Measure Information:
Title
Quality of Life (QOL)
Description
Quality of life as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). KCCQE is a 23-item self-administered questionnaire developed to independently measure the patient's perception of their health status, which includes heart failure symptoms, impact on physical and social function, and how their heart failure impacts their quality of life (QOL) within a 2-week recall period. KCCQ responses are provided along a rating scale continuum with equal spacing from worst to best.
Time Frame
One year
Secondary Outcome Measure Information:
Title
LOS
Description
Length of stay post TAVR
Time Frame
Index hospitalization
Title
MACE
Description
Composite of mortality and repeat hospitalization
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Short Physical Performance Battery Protocol (SPPB) score < 9
Exclusion Criteria:
Severe liver disease defined by Childs Pugh class >B or MELD score >15.
Severe kidney disease defined by eGFR <30 mL/min.
Hospital admission during the 4 weeks prior to randomization.
Montreal objective cognitive assessment (MOCA) score <18.
Mechanical fall in the past month.
Unstable angina during the previous month.
Myocardial infarction during the previous month.
Unsuccessful completion of the one-week run-in phase.
Syncopal episode during exercise during run-in phase
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Syed Ishba
Phone
416-620-9600
Email
ishba.syed@unityhealth.to
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Asim Cheema, MD
Organizational Affiliation
Unity Health Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Southlake Hospital
City
Newmarket
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Asim Cheema, MD
Phone
416-620-9600
Email
acheema@southlakeregional.org
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33962483
Citation
Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2021 May 7;5(5):CD010876. doi: 10.1002/14651858.CD010876.pub3.
Results Reference
derived
Learn more about this trial
Physiological Reconditioning Program Administered Remotely in Patients Undergoing Transcatheter Aortic Valve Replacement: A Pilot Study
We'll reach out to this number within 24 hrs